echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Production Process of 8-Hydroxyimidazo[1,2-a]pyridine, HCl

    The Production Process of 8-Hydroxyimidazo[1,2-a]pyridine, HCl

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    8-Hydroxyimidazo[1,2-a]pyridine, HCl is a compound that is widely used in the pharmaceutical industry as an intermediate for the synthesis of various drugs.
    The production process of 8-hydroxyimidazo[1,2-a]pyridine, HCl involves several steps, each of which is carefully designed to yield the desired product while minimizing the formation of unwanted by-products.


    The starting material for the production of 8-hydroxyimidazo[1,2-a]pyridine, HCl is 2-oxooxazolidin-3-one, which is obtained by a series of chemical reactions involving nitration, hydrolysis, and condensation.
    The 2-oxooxazolidin-3-one is then converted into 8-hydroxyimidazo[1,2-a]pyridine, HCl through a series of chemical reactions that involve oxidation, condensation, and hydrolysis.


    The production process of 8-hydroxyimidazo[1,2-a]pyridine, HCl can be divided into several stages, each of which involves specific chemical reactions and purification steps to remove unwanted by-products.
    The following is a detailed description of the production process of 8-hydroxyimidazo[1,2-a]pyridine, HCl:


    Stage 1: Nitration of 2-oxooxazolidin-3-one
    The first step in the production of 8-hydroxyimidazo[1,2-a]pyridine, HCl is the nitration of 2-oxooxazolidin-3-one.
    This is accomplished by treating 2-oxooxazolidin-3-one with nitric acid to form 2-nitrooxazolidin-3-one.
    This reaction is carried out in the presence of an organic solvent, such as acetonitrile, and a catalyst, such as sulfuric acid.


    Stage 2: Hydrolysis of 2-nitrooxazolidin-3-one
    The next step in the production of 8-hydroxyimidazo[1,2-a]pyridine, HCl is the hydrolysis of 2-nitrooxazolidin-3-one.
    This is accomplished by treating 2-nitrooxazolidin-3-one with water in the presence of a strong acid catalyst, such as sulfuric acid.
    This step results in the formation of 2-oxooxazolidin-3-one again, but with a nitro group attached to the carbon atom at position 2.


    Stage 3: Condensation of 2-nitrooxazolidin-3-one
    The next step in the production of 8-hydroxyimidazo[1,2-a]pyridine, HCl is the condensation of 2-nitrooxazolidin-3-one.
    This is accomplished by treating 2-nitrooxazolidin-3-one with an aqueous solution of sodium hydroxide.
    This step results in the formation of 2-oxooxazolidin-3-one again, but with the nitro group at position 2 replaced by a hydroxy group.


    Stage 4: Oxidation of 2-oxooxazolidin-3-one
    The next step in the production of 8-hydroxyimidazo[1,2-a]pyridine, HCl is the oxidation of 2-oxooxazolidin-3-one.
    This is accomplished by treating 2-oxooxazolidin-3-one with an oxidizing agent, such as potassium permanganate, in the presence of an organic sol


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.